Group 1 - The core point of the announcement is that Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has received approval from the China Securities Regulatory Commission (CSRC) to publicly issue technology innovation corporate bonds with a total face value of up to RMB 6 billion [1][2] - The approval is valid for 24 months from the date of registration, allowing the company to issue the bonds in tranches based on funding needs and market conditions [1][3] - The company commits to fulfilling disclosure obligations in accordance with relevant laws and regulations during the bond issuance process [1][2] Group 2 - The company has also conducted a self-examination regarding insider trading related to the planned spin-off of its subsidiary, Fosun Antigen (Chengdu) Biopharmaceutical Co., Ltd., for listing on the Hong Kong Stock Exchange [3][4] - The self-examination period for insider trading was set from April 28, 2025, to January 22, 2026, covering the time before the board's first resolution on the spin-off [5][6] - The company confirmed that no insider trading occurred during the self-examination period, and necessary confidentiality measures were implemented to control the range of insider information [19][20]

Core Viewpoint - Fosun Pharma has received approval from the China Securities Regulatory Commission (CSRC) to publicly issue technology innovation corporate bonds with a total face value of up to RMB 6 billion [1] Group 1 - The approval allows Fosun Pharma to issue the bonds to professional investors within a validity period of 24 months from the date of approval [1] - The company plans to issue the bonds in phases based on funding needs and market conditions during the registration validity period [1] - Fosun Pharma will comply with relevant laws, regulations, and disclosure obligations as required by the approval and authorized by its shareholders [1]

Core Viewpoint - CATL (宁德时代) announced the issuance of corporate bonds aimed at professional investors, with a total scale not exceeding 5 billion yuan, to support various financial needs [1] Group 1: Bond Issuance Details - The bond issuance is part of the company's strategy to raise funds for project construction, working capital, and repayment of interest-bearing debts [1] - The coupon rate for the bonds is expected to be in the range of 1.60% to 2.20% [1] - The total issuance scale is capped at 5 billion yuan, including the full amount [1]

Group 1 - The company, CITIC Securities, plans to issue a public offering of corporate bonds aimed at professional investors from January 29 to January 30, 2026 [1] - The total amount of the bond issuance will not exceed 1.5 billion yuan, with a maturity period of 3 years and a face value of 100 yuan, issued at par [1] - At least 70% of the funds raised from this bond issuance will be used for investments that meet capital market requirements, including but not limited to replacing contributions to the Chunlin Qinchang (Hangzhou) Science and Technology Innovation Venture Capital Partnership [1]

Meeting Overview - The first extraordinary general meeting of shareholders was held on January 26, 2026, at the company's conference room [2] - The meeting was convened by the board of directors and chaired by Mr. Feng Yong, with both on-site and online voting methods employed [2][3] - The meeting was witnessed by lawyers from Guohao Law Firm (Xi'an) [8] Voting Results - All proposed resolutions were approved without any objections [2] - Key resolutions included amendments to the company's articles of association, rules for shareholder meetings, rules for board meetings, and the 2026 annual related party transaction plan [4][5] - The proposal for the registration and issuance of technology innovation corporate bonds was also approved [5] Legal Compliance - The meeting's procedures were confirmed to comply with relevant laws and regulations, including the Company Law and Securities Law [8] - The qualifications of attendees and the convenor were deemed valid, and the voting procedures and results were confirmed as legal and effective [8]

Core Viewpoint - China International Capital Corporation (CICC) announced the issuance of technology innovation corporate bonds aimed at professional investors, with a total issuance scale not exceeding RMB 5 billion [1] Group 1 - The bond issuance consists of two varieties, with each variety having an issuance amount not exceeding RMB 5 billion [1] - Variety one is referred to as "26 CICC K1" with bond code 244614, while variety two is referred to as "26 CICC K2" with bond code 244615 [1] - Each bond has a face value of RMB 100, and the issuance price is set at RMB 100 per bond [1]

Group 1 - The core point of the article is that China National Building Material (03323) announced the issuance of technology innovation corporate bonds aimed at professional investors, with a total issuance scale of no more than 2 billion yuan [1] - The bonds are divided into two varieties, with the first variety having a term of 3 years and the second variety having a term of 5 years [1] - The coupon rate for the first variety of bonds has been set at 1.77% based on the results of inquiries from professional institutional investors, while the second variety was not actually issued [1]

Core Viewpoint - China National Building Material (03323) announced the issuance of corporate bonds aimed at professional investors, with a total scale not exceeding 2 billion yuan [1] Group 1: Bond Issuance Details - The company plans to issue the first phase of technology innovation corporate bonds with a total scale of up to 2 billion yuan [1] - The bonds are divided into two varieties, with the first variety having a maturity of 3 years and the second variety having a maturity of 5 years [1] - The coupon rate for the first variety of bonds has been set at 1.77%, while the second variety was not actually issued [1]

Group 1 - The core point of the article is that Changjiang Securities has received approval from the China Securities Regulatory Commission (CSRC) to publicly issue technology innovation corporate bonds to professional investors [1] - The total face value of the bonds to be issued will not exceed 1 billion yuan [1] - The approval is valid for 24 months from the date of registration, allowing the company to issue the bonds in multiple tranches within this period [1]

Group 1 - The company has adjusted its board's strategic committee to a strategic and sustainable development committee to enhance governance and sustainability capabilities [1][2] - The new committee will include responsibilities related to ESG (Environmental, Social, and Governance) and sustainable development [2] - Amendments to the company's articles of association and management systems are proposed to align with the new committee's focus [3][4] Group 2 - The company plans to apply for the issuance of technology innovation corporate bonds to broaden financing channels and optimize debt structure [6][10] - The total amount of the proposed bond issuance is up to 2 billion RMB [7] - The issuance plan requires approval from the shareholders' meeting and will be valid upon registration and issuance [9] Group 3 - The company has announced its expected daily related transactions for 2026, which are based on normal business operations and market pricing [13][14] - The independent directors have approved the daily related transaction plan, confirming it does not affect the company's independence or harm shareholder interests [15][16] - The expected transactions will involve purchasing raw materials and services from related parties, adhering to fair pricing principles [32][33] Group 4 - The company intends to use part of its idle raised funds to temporarily supplement working capital, not exceeding 200 million RMB [35][36] - This temporary funding will be used for operational needs without affecting the progress of investment projects [38][39] - The decision to use idle funds has been approved by the board and complies with regulatory requirements [41][40]